Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Human Antibodies|May 26, 2019
Leydig cells express the FABP9 in human testisAfshin Moradi, Farzad S Forootan, Masoumeh Hosseini, et al.Genes & Cancer|July 26, 2014
Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancerDanqing Chen, Shiva S Forootan, John R Gosney, et al.International Journal of Oncology|December 4, 2009
Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenograftsShiva S Forootan, Zheng Z Bao, Farzad S Forootan, et al.International Journal of Oncology|November 6, 2013
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancerFarzad S Forootan, Shiva S Forootan, Mohammed I Malki, et al.Genes & Cancer|October 30, 2013
A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cellsZhengzheng Bao, Mohammad I Malki, Shiva S Forootan, et al.Oncotarget|August 22, 2020
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Waseem Al-Jameel, Xiaojun Gou, Shiva S Forootan, et al.Oncotarget|April 19, 2017
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Waseem Al-Jameel, Xiaojun Gou, Shiva S Forootan, et al.Oncotarget|January 28, 2016
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoterFarzad S Forootan, Shiva S Forootan, Xiaojun Gou, et al.Pageof 1